LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial

OBJECTIVE: As glucagon-like peptide-1 receptor agonists lower blood pressure (BP) in type 2 diabetes mellitus (T2DM), we examined BP control in relation to targets set by international bodies prior to randomization in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcom...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Hypertens
Main Authors: Petrie, John R., Marso, Steven P., Bain, Stephen C., Franek, Edward, Jacob, Stephan, Masmiquel, Luis, Leiter, Lawrence A., Haluzik, Martin, Satman, Ilhan, Omar, Mohamed, Shestakova, Marina, Van Gaal, Luc, Mann, Johannes F., Baeres, Florian M.M., Zinman, Bernard, Poulter, Neil R.
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2016
Assuntos:
ORIGINAL PAPERS: Diabetes mellitus
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4856174/
https://ncbi.nlm.nih.gov/pubmed/26855018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HJH.0000000000000890
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares